Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Journal of Virology|August 4, 2022
A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 InfectionRana Abdelnabi, Caroline S Foo, Suzanne J F Kaptein, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 6, 2012
MAPPIT as a high-throughput screening assay for modulators of protein-protein interactions in HIV and HCVBertrand Van Schoubroeck, Koen Van Acker, Géry Dams, et al.
European Journal of Medicinal Chemistry|December 4, 2025
Thiazolyl 4-carboxylate ketone as a new warhead for a highly potent SARS-CoV-2 main protease inhibitorMaria A Theodoropoulou, Haifa El Kilani, Christiana Mantzourani, et al.
Pharmaceutics|May 27, 2023
Urtica dioica Agglutinin Prevents Rabies Virus Infection in a Muscle Explant ModelXinyu Wang, Lisanne Terrie, Guanghui Wu, et al.
Nature Chemical Biology|October 23, 2020
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imagingWioletta Rut, Katarzyna Groborz, Linlin Zhang, et al.
Antiviral Research|November 7, 2024
The effects of Remdesivir's functional groups on its antiviral potency and resistance against the SARS-CoV-2 polymeraseBhawna Sama, Barbara Selisko, Camille Falcou, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2009
TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1Hilde Azijn, Ilse Tirry, Johan Vingerhoets, et al.
Angewandte Chemie (International Ed. in English)|March 22, 2021
Chemical Evolution of Antivirals Against Enterovirus D68 through Protein-Templated Knoevenagel ReactionsCarolin Tauber, Rebekka Wamser, Christoph Arkona, et al.
Ebiomedicine|May 6, 2023
Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamstersElise Wouters, Caro Verbrugghe, Rana Abdelnabi, et al.
Pageof 12